Mater Misericordiae University Hospital (MMUH) / Ospidéal an Mater Misercordiae

Hospital


Location: Dublin, Ireland (IE) IE

ISNI: 0000000404888430

ROR: https://ror.org/040hqpc16

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

INDUCIBLE MMP-3 EXPRESSION IN A STEROID-INDUCED MURINE MODEL OF GLAUCOMA (2018) O'Callaghan J, Cassidy PS, Reina-Torres E, Sherwood J, Humphries MM, Campbell M, O'Brien CJ, et al. Conference contribution Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study (2017) Higgins M, Curigliano G, Dieras V, Kuemmel S, Kunz G, Fasching P, Campone M, et al. Journal article Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma (2017) O'Callaghan J, Crosbie DE, Cassidy PS, Sherwood JM, Flügel-Koch C, Lütjen-Drecoll E, Humphries MM, et al. Journal article Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial (2015) Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, Mcmurdo MET, et al. Journal article Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project+ (2015) Kramar A, Negrier S, Sylvester R, Joniau S, Mulders P, Powles T, Bex A, et al. Journal article Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial (2015) Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, Mcmurdo MET, et al. Journal article